SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Robério A. A. Pondé, Atypical serological profiles in hepatitis B virus infection, European Journal of Clinical Microbiology & Infectious Diseases, 2013, 32, 4, 461

    CrossRef

  2. 2
    Mohammad Asim, Manash Pratim Sarma, Premashis Kar, Etiological and molecular profile of hepatocellular cancer from India, International Journal of Cancer, 2013, 133, 2
  3. 3
    Winnie Yeo, Henry LY Chan, Hepatitis B virus reactivation associated with anti-neoplastic therapy, Journal of Gastroenterology and Hepatology, 2013, 28, 1
  4. You have free access to this content4
    Ankur Jindal, Manoj Kumar, Shiv K. Sarin, Management of acute hepatitis B and reactivation of hepatitis B, Liver International, 2013, 33,
  5. 5
    Giovanni Raimondo, Gaia Caccamo, Roberto Filomia, Teresa Pollicino, Occult HBV infection, Seminars in Immunopathology, 2013, 35, 1, 39

    CrossRef

  6. 6
    Loredana Covolo, Teresa Pollicino, Giovanni Raimondo, Francesco Donato, Occult hepatitis B virus and the risk for chronic liver disease: A meta-analysis, Digestive and Liver Disease, 2013, 45, 3, 238

    CrossRef

  7. 7
    Ryu Watanabe, Tomonori Ishii, Kyohei Nakamura, Tsuyoshi Shirai, Yumi Tajima, Hiroshi Fujii, Hideo Harigae, Prevalence and time course of hepatitis B virus infection in patients with systemic lupus erythematosus under immunosuppressive therapy, Modern Rheumatology, 2013, 23, 6, 1094

    CrossRef

  8. 8
    Fugui Bai, Yoshihiko Yano, Takumi Fukumoto, Atsushi Takebe, Motofumi Tanaka, Kaori Kuramitsu, Nungki Anggorowati, Hanggoro Tri Rinonce, Dewiyani Indah Widasari, Masaya Saito, Hirotaka Hirano, Takanobu Hayakumo, Yasushi Seo, Takeshi Azuma, Yonson Ku, Yoshitake Hayashi, Quantification of Pregenomic RNA and Covalently Closed Circular DNA in Hepatitis B Virus-Related Hepatocellular Carcinoma, International Journal of Hepatology, 2013, 2013, 1

    CrossRef

  9. 9
    Patricia Araujo, Roger Y. Dodd, Flavia Latinni, Renata Souza, Ricardo Diaz, Jose Augusto Barreto, T-Cell Response to Hepatitis B Core Antigen: Identification of Prior Exposure to and Confirmatory Testing for Screening for Anti-HBc, Journal of Biomarkers, 2013, 2013, 1

    CrossRef

  10. 10
    Jie-Wen PENG, Gui-Nan LIN, Jian-jun XIAO, Xiao-Mei JIANG, Hepatitis B virus reactivation in hepatocellular carcinoma patients undergoing transcatheter arterial chemoembolization therapy, Asia-Pacific Journal of Clinical Oncology, 2012, 8, 4
  11. 11
    KASL Clinical Practice Guidelines: Management of chronic hepatitis B, Clinical and Molecular Hepatology, 2012, 18, 2, 109

    CrossRef

  12. 12
    Masashi MIZOKAMI, Masaya SUGIYAMA, Present state and the future direction of HBV vaccine, Uirusu, 2012, 62, 1, 67

    CrossRef

  13. 13
    Ryu Watanabe, Tomonori Ishii, Kyohei Nakamura, Tsuyoshi Shirai, Yumi Tajima, Hiroshi Fujii, Hideo Harigae, Prevalence and time course of hepatitis B virus infection in patients with systemic lupus erythematosus under immunosuppressive therapy, Modern Rheumatology, 2012,

    CrossRef

  14. 14
    Eiji Tanaka, Yukitomo Urata, Risk of hepatitis B reactivation in patients treated with tumor necrosis factor-α inhibitors, Hepatology Research, 2012, 42, 4
  15. 15
    Suk Jin Hong, Byung-Ho Choe, Strategy to Overcome Drug Resistance That Develops during Treatment of Chronic Hepatitis B in Children, Pediatric Gastroenterology, Hepatology & Nutrition, 2012, 15, 2, 63

    CrossRef

  16. 16
    Suk Jin Hong, Byung-Ho Choe, Strategy to Overcome Drug Resistance That Develops during Treatment of Chronic Hepatitis B in Children, Pediatric Gastroenterology, Hepatology & Nutrition, 2012, 15, 2, 63

    CrossRef

  17. 17
    G.Y. Minuk, K. Kowalec, S. Caouette, B. Larke, C. Osiowy, The prevalence and long term outcome of occult hepatitis B virus infections in community based populations, Journal of Medical Virology, 2012, 84, 9
  18. 18
    Hiroshi Yotsuyanagi, Yasuhito Tanaka, Akihiko Saitoh, Takeji Umemura, Kiyoaki Ito, Masataka Tsuge, Shoichi Takahashi, Hiroyuki Nakanishi, Kanako Yoshida, Satoru Sekoguchi, Hideaki Takahashi, Kazuhiko Hayashi, Hitoshi Tajiri, Haruki Komatsu, Fuminaka Sugauchi, Kazuto Tajiri, Yoshihide Ueda, Chiaki Okuse, Hiroshi Yatsuhashi, Masashi Mizokami, Universal vaccination of hepatitis B virus vaccine, Kanzo, 2012, 53, 2, 117

    CrossRef

  19. You have free access to this content19
    L. K. King, A. Lee, A. Anandacoomarasamy, Use of biological disease-modifying anti-rheumatic drugs in patients with concurrent rheumatic disease and hepatitis B, Internal Medicine Journal, 2012, 42, 5
  20. 20
    D. Robert Dufour, Tietz Textbook of Clinical Chemistry and Molecular Diagnostics, 2012,

    CrossRef

  21. 21
    Hye Jin Choi, Soon Young Ko, Won Hyeok Choe, Yeon Seok Seo, Ji Hoon Kim, Kwan Soo Byun, Young Seok Kim, Seung Up Kim, Soon Koo Baik, Jae Youn Cheong, Tae Yeob Kim, Oh Sang Kwon, Jeong Han Kim, Chang Hong Lee, So Young Kwon, Clinical features of acute viral hepatitis B in Korea: a multi-center study, The Korean Journal of Hepatology, 2011, 17, 4, 307

    CrossRef

  22. 22
    Z.-H. Zhang, L. Li, X.-P. Zhao, D. Glebe, C. M. Bremer, Z.-M. Zhang, Y.-J. Tian, B.-J. Wang, Y. Yang, W. Gerlich, M. Roggendorf, X. Li, M. Lu, D.-L. Yang, Elimination of hepatitis B virus surface antigen and appearance of neutralizing antibodies in chronically infected patients without viral clearance, Journal of Viral Hepatitis, 2011, 18, 6
  23. 23
    F. Marcucci, A. Mele, Hepatitis viruses and non-Hodgkin lymphoma: epidemiology, mechanisms of tumorigenesis, and therapeutic opportunities, Blood, 2011, 117, 6, 1792

    CrossRef

  24. 24
    Y. Bouike, S. Imoto, O. Mabuchi, A. Kokubunji, S. Kai, M. Okada, R. Taniguchi, S. Momose, S. Uchida, H. Nishio, Infectivity of HBV DNA positive donations identified in look-back studies in Hyogo-Prefecture, Japan, Transfusion Medicine, 2011, 21, 2
  25. 25
    Andrea Costantini, Katia Marinelli, Giulia Biagioni, Alessia Monachetti, Monica L Ferreri, Luca Butini, Maria Montroni, Aldo Manzin, Patrizia Bagnarelli, Molecular analysis of hepatitis B virus (HBV) in an HIV co-infected patient with reactivation of occult HBV infection following discontinuation of lamivudine-including antiretroviral therapy, BMC Infectious Diseases, 2011, 11, 1, 310

    CrossRef

  26. 26
    Yukitomo Urata, Ryoko Uesato, Dai Tanaka, Kenji Kowatari, Taisuke Nitobe, Yoshihide Nakamura, Shigeru Motomura, Prevalence of reactivation of hepatitis B virus replication in rheumatoid arthritis patients, Modern Rheumatology, 2011, 21, 1, 16

    CrossRef

  27. 27
    Yukitomo Urata, Ryoko Uesato, Dai Tanaka, Kenji Kowatari, Taisuke Nitobe, Yoshihide Nakamura, Shigeru Motomura, Prevalence of reactivation of hepatitis B virus replication in rheumatoid arthritis patients, Modern Rheumatology, 2011, 21, 1, 16

    CrossRef

  28. 28
    Philip A. Thompson, Constantine S. Tam, Karin Thursky, John F. Seymour, Hepatitis-B reactivation and rituximab-containing chemotherapy: an increasingly complex clinical challenge, Leukemia & Lymphoma, 2010, 51, 9, 1592

    CrossRef

  29. 29
    F. B. Hollinger, G. Sood, Occult hepatitis B virus infection: a covert operation, Journal of Viral Hepatitis, 2010, 17, 1
  30. 30
    Eduardo Muñoz Bertrán, Elena Pérez Ceballos, Rosa Gómez Espín, Isabel Ortega González, Reactivación de la hepatitis B en un paciente HBsAg negativo/antiHBc positivo con linfoma B que recibió quimioterapia con rituximab, Gastroenterología y Hepatología, 2010, 33, 5, 377

    CrossRef

  31. 31
    Ji Hoon Kim, Clinical outcomes and development of hepatocellular carcinoma after HBsAg seroclearance in chronic hepatitis B patients, The Korean Journal of Hepatology, 2009, 15, 3, 383

    CrossRef

  32. 32
    Jay H. Hoofnagle, Reactivation of hepatitis B, Hepatology, 2009, 49, S5
  33. 33
    Steven K. Herrine, Simona Rossi, Victor J. Navarro, Pharmacology and Therapeutics, 2009,

    CrossRef

  34. 34
    H.P. Dienes, U. Drebber, Aktuelle Probleme der Hepatitis, Der Pathologe, 2008, 29, S2, 286

    CrossRef

  35. 35
    Katsuaki Tanaka, Does occult hepatitis B virus infection cause hepatocellular carcinoma in patients with chronic liver disease related to hepatitis C virus?, Hepatology Research, 2008, 38, 6
  36. 36
    Mikako Obika, Toshiyuki Shinji, Shin-ichi Fujioka, Ryo Terada, Hiromasa Ryuko, Aye Aye Lwin, Hidenori Shiraha, Norio Koide, Hepatitis B Virus DNA in Liver Tissue and Risk for Hepatocarcinogenesis in Patients with Hepatitis C Virus-Related Chronic Liver Disease, Intervirology, 2008, 51, 1, 59

    CrossRef

  37. 37
    Eiji Tanaka, Takeji Umemura, History and prevention of de novo hepatitis B virus-related hepatitis in Japan and the world, Clinical Journal of Gastroenterology, 2008, 1, 3, 83

    CrossRef

  38. 38
    Mehmet Demir, Ender Serin, Savaş Göktürk, Nevin Akcaer Ozturk, Sevsen Kulaksizoglu, Uğur Ylmaz, The prevalence of occult hepatitis B virus infection in type 2 diabetes mellitus patients, European Journal of Gastroenterology & Hepatology, 2008, 20, 7, 668

    CrossRef

  39. 39
    M. Kumar, S. Satapathy, R. Monga, K. Das, S. Hissar, C. Pande, B. C. Sharma, S. K. Sarin, A randomized controlled trial of lamivudine to treat acute hepatitis B, Hepatology, 2007, 45, 1
  40. 40
    Atsunori Kusakabe, Yasuhito Tanaka, Etsuro Orito, Fuminaka Sugauchi, Fuat Kurbanov, Tomoyuki Sakamoto, Noboru Shinkai, Noboru Hirashima, Izumi Hasegawa, Tomoyoshi Ohno, Ryuzo Ueda, Masashi Mizokami, A weak association between occult HBV infection and non-B non-C hepatocellular carcinoma in Japan, Journal of Gastroenterology, 2007, 42, 4, 298

    CrossRef

  41. 41
    Nurten Savas, Turan Colak, Ugur Yilmaz, Remzi Emiroglu, Mehmet Haberal, Hepatitis B virus reactivation after renal transplantation: report of two cases, Transplant International, 2007, 20, 3
  42. 42
    Hashem B. El–Serag, K. Lenhard Rudolph, Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis, Gastroenterology, 2007, 132, 7, 2557

    CrossRef

  43. 43
    Stephan Menne, Paul J. Cote, Scott D. Butler, Ilia A. Toshkov, John L. Gerin, Bud C. Tennant, Immunosuppression reactivates viral replication long after resolution of woodchuck hepatitis virus infection, Hepatology, 2007, 45, 3
  44. 44
    Masahiro Satake, Rikizo Taira, Hisao Yugi, Satoru Hino, Kimihiro Kanemitsu, Hisami Ikeda, Kenji Tadokoro, Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program, Transfusion, 2007, 47, 7
  45. 45
    Akira Yoshikawa, Yuko Gotanda, Kiyoshi Minegishi, Rikizo Taira, Satoru Hino, Kenji Tadokoro, Hitoshi Ohnuma, Keiko Miyakawa, Katsumi Tachibana, Hideaki Mizoguchi, Lengths of hepatitis B viremia and antigenemia in blood donors: preliminary evidence of occult (hepatitis B surface antigen–negative) infection in the acute stage, Transfusion, 2007, 47, 7
  46. 46
    Tomasz I Michalak, Tram NQ Pham, Patricia M Mulrooney-Cousins, Molecular diagnosis of occult HCV and HBV infections, Future Virology, 2007, 2, 5, 451

    CrossRef

  47. 47
    Surakit Pungpapong, W. Ray Kim, John J. Poterucha, Natural History of Hepatitis B Virus Infection: An Update for Clinicians, Mayo Clinic Proceedings, 2007, 82, 8, 967

    CrossRef

  48. 48
    Giovanni Raimondo, Teresa Pollicino, Irene Cacciola, Giovanni Squadrito, Occult hepatitis B virus infection, Journal of Hepatology, 2007, 46, 1, 160

    CrossRef

  49. 49
    Manoj Kumar, Rakesh Kumar, Syed S Hissar, Manoj Kumar Saraswat, Barjesh Chander Sharma, Puja Sakhuja, Shiv Kumar Sarin, Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: A case–control study of 213 hepatocellular carcinoma patients from India, Journal of Gastroenterology and Hepatology, 2007, 22, 7
  50. 50
    Alessandro R. Zanetti, Luisa Romanò, Alessandra Zappá, Claudio Velati, Changing patterns of hepatitis B infection in Italy and NAT testing for improving the safety of blood supply, Journal of Clinical Virology, 2006, 36, S51

    CrossRef

  51. 51
    Takeji Umemura, Kendo Kiyosawa, Fatal HBV Reactivation in a Subject with Anti-HBs and Anti-HBc, Internal Medicine, 2006, 45, 12, 747

    CrossRef

  52. 52
    Stephan Günther, Genetic variation in HBV infection: genotypes and mutants, Journal of Clinical Virology, 2006, 36, S3

    CrossRef

  53. 53
    Hyung Joon Yim, Anna Suk-Fong Lok, Natural history of chronic hepatitis B virus infection: What we knew in 1981 and what we know in 2005, Hepatology, 2006, 43, S1
  54. 54
    Nayar Manu, Porooshani Amir, Mario Pinto, Chandy Rajiv, Reactivation of Hepatitis B in an Elderly Patient With Chronic Lymphatic Leukemia, Journal of Clinical Gastroenterology, 2006, 40, 8, 762

    CrossRef

  55. 55
    JAEJUN SHIM, BYUNG-HO KIM, NAM HOON KIM, SEOK HO DONG, HYO JONG KIM, YOUNG WOON CHANG, JOUNG IL LEE, RIN CHANG, Clinical features of HBsAg-negative but anti-HBc-positive hepatocellular carcinoma in a hepatitis B virus endemic area, Journal of Gastroenterology and Hepatology, 2005, 20, 5
  56. 56
    Meike Hass, Charles Hannoun, Tatyana Kalinina, Gunhild Sommer, Christoph Manegold, Stephan Günther, Functional analysis of hepatitis B virus reactivating in hepatitis B surface antigen-negative individuals, Hepatology, 2005, 42, 1
  57. 57
    Akira Yoshikawa, Yuhko Gotanda, Masako Itabashi, Kiyoshi Minegishi, Kimihiro Kanemitsu, Kusuya Nishioka, Hepatitis B NAT virus-positive blood donors in the early and late stages of HBV infection: analyses of the window period and kinetics of HBV DNA, Vox Sanguinis, 2005, 88, 2
  58. 58
    Sang Hoon Ahn, Young Nyun Park, Jun Yong Park, Hye-Young Chang, Jung Min Lee, Ji Eun Shin, Kwang-Hyub Han, Chanil Park, Young Myoung Moon, Chae Yoon Chon, Long-term clinical and histological outcomes in patients with spontaneous hepatitis B surface antigen seroclearance, Journal of Hepatology, 2005, 42, 2, 188

    CrossRef

  59. 59
    Bernard Weber, Annemarie Berger, Molecular detection of hepatitis B virus: recent developments. Molekularer Nachweis des Hepatitis B-Virus: Aktueller Entwicklungsstand, LaboratoriumsMedizin, 2005, 29, 1, 33

    CrossRef

  60. 60
    K. Pogány, H.L. Zaaijer, J.M. Prins, F.W. Wit, J.M.A. Lange, M.G.H.M. Beld, Occult Hepatitis B Virus Infection before and 1 Year after Start of HAART in HIV Type 1-Positive Patients, AIDS Research and Human Retroviruses, 2005, 21, 11, 922

    CrossRef

  61. 61
    Gerald Y. Minuk, Dong-feng Sun, Julia Uhanova, Manna Zhang, Shauna Caouette, Lindsay E. Nicolle, Adam Gutkin, Karen Doucette, Bruce Martin, Antonio Giulivi, Occult hepatitis B virus infection in a North American community-based population, Journal of Hepatology, 2005, 42, 4, 480

    CrossRef

  62. 62
    C. Cooper, D. Kilby, Clinical Significance of Hepatitis B Core Antibody Positivity in HCV-Infected and HCV/HIV Coinfected Individuals, Clinical Infectious Diseases, 2004, 38, 9, 1335

    CrossRef

  63. 63
    TEH-IA HUO, JAW-CHING WU, Does antibody to hepatitis B surface antigen protect renal transplant patients from hepatitis B?, Journal of Gastroenterology and Hepatology, 2004, 19, 8
  64. 64
    KYUN-HWAN KIM, SANG HOON AHN, HYO YOUNG CHUNG, YONG HAN PAIK, KWAN SIK Lee, YU SEUN KIM, CHAE YOON CHON, YOUNG MYOUNG MOON, KWANG-HYUB HAN, Hepatitis B virus infection after renal transplantation in the presence of antibody to hepatitis B surface antigen immunity, Journal of Gastroenterology and Hepatology, 2004, 19, 8
  65. 65
    Jay H. Lefkowitch, Hepatobiliary pathology, Current Opinion in Gastroenterology, 2004, 20, 3, 188

    CrossRef

  66. 66
    Michael Torbenson, Rajesh Kannangai, Jacquie Astemborski, Steffanie A. Strathdee, David Vlahov, David L. Thomas, High prevalence of occult hepatitis B in Baltimore injection drug users, Hepatology, 2004, 39, 1
  67. 67
    Curtis L Cooper, D William Cameron, Interpretation of undetectable hepatitis C virus RNA levels in HIV-hepatitis C virus co-infection, AIDS, 2004, 18, 2, 337

    CrossRef

  68. 68
    H. Schmilovitz-Weiss, Z. Ben-Ari, E. Sikuler, E. Zuckerman, W. Sbeit, Z. Ackerman, R. Safadi, Y. Lurie, G. Rosner, R. Tur-Kaspa, R. Reshef, Lamivudine treatment for acute severe hepatitis B: a pilot study, Liver International, 2004, 24, 6
  69. 69
    R. Kannangai, E. Molmenti, L. Arrazola, A. Klein, M. Choti, D. L. Thomas, M. Torbenson, Occult hepatitis B viral DNA in liver carcinomas from a region with a low prevalence of chronic hepatitis B infection, Journal of Viral Hepatitis, 2004, 11, 4
  70. 70
    Jean-Pierre Allain, Occult hepatitis B virus infection, Transfusion Clinique et Biologique, 2004, 11, 1, 18

    CrossRef

  71. 71
    Valeria Ghisetti, Alfredo Marzano, Fausto Zamboni, Anna Barbui, Alessandro Franchello, Silvia Gaia, Giovanna Marchiaro, Mauro Salizzoni, Mario Rizzetto, Occult hepatitis B virus infection in HBsAg negative patients undergoing liver transplantation: Clinical significance, Liver Transplantation, 2004, 10, 3
  72. 72
    Jorge A. Marrero, Anna S.F. Lok, Occult hepatitis B virus infection in patients with hepatocellular carcinoma: innocent bystander, cofactor, or culprit?, Gastroenterology, 2004, 126, 1, 347

    CrossRef

  73. 73
    ANNA SF LOK, Occult hepatitis B virus infection: diagnosis, implications and management?, Journal of Gastroenterology and Hepatology, 2004, 19,
  74. 74
    J.-P. Allain, Occult hepatitis B virus infection: implications in transfusion, Vox Sanguinis, 2004, 86, 2
  75. 75
    Carla S. Coffin, Tram N.Q. Pham, Patricia M. Mulrooney, Norma D. Churchill, Tomasz I. Michalak, Persistence of isolated antibodies to woodchuck hepatitis virus core antigen is indicative of occult infection, Hepatology, 2004, 40, 5
  76. 76
    Anna S.F. Lok, Prevention of hepatitis B virus–related hepatocellular carcinoma, Gastroenterology, 2004, 127, 5, S303

    CrossRef